Insider · CIK 0001816160
James Kihara
officer
Files at ACAD (ACADIA PHARMACEUTICALS INC). First filing Nov 19, 2024, latest May 19, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $221k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ACAD: ACADIA PHARMACEUTICALS INC
ACADOct 9, 2026 · close 19.78
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | ACADIA PHARMACEUTICALS INC | $90k 4,000 shares | -16% | +58% from low0% from high | |
| 0Weak | ACADIA PHARMACEUTICALS INC | $19k 1,327 shares | -5% | +6% from low-27% from high | |
| 0Weak | ACADIA PHARMACEUTICALS INC | $15k 1,028 shares | -4% | 0% from low-31% from high | |
| 0Weak | ACADIA PHARMACEUTICALS INC | $19k 1,095 shares | -5% | +19% from low-16% from high | |
| 0Weak | ACADIA PHARMACEUTICALS INC | $9,481 475 shares | -2% | +36% from low-4% from high | |
| 8Weak | ACADIA PHARMACEUTICALS INC | $68k 4,073 shares | -17% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 16, 2025 | ACAD ACADIA PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -2,000 | $25.00 | $50k | 22,395 | May 19, 2025 |
| May 16, 2025 | ACAD ACADIA PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -2,000 | $20.00 | $40k | 20,395 | May 19, 2025 |
| May 1, 2025 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Common Stock | +2,596 | - | - | 24,853 | May 2, 2025 |
| May 2, 2025 | ACAD ACADIA PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,327 | $14.60 | $19k | 23,526 | May 2, 2025 |
| May 1, 2025 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitsderivative | -2,596 | $0.00 | $0 | 5,192 | May 2, 2025 |
| Apr 5, 2025 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Common Stock | +2,010 | - | - | 23,285 | Apr 8, 2025 |
| Apr 8, 2025 | ACAD ACADIA PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,028 | $14.82 | $15k | 22,257 | Apr 8, 2025 |
| Apr 5, 2025 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitsderivative | -2,010 | $0.00 | $0 | 2,010 | Apr 8, 2025 |
| Mar 25, 2025 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Common Stock | +2,142 | - | - | 22,370 | Mar 26, 2025 |
| Mar 26, 2025 | ACAD ACADIA PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,095 | $17.05 | $19k | 21,275 | Mar 26, 2025 |
| Mar 24, 2025 | ACAD ACADIA PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +22,152 | $0.00 | $0 | 22,152 | Mar 26, 2025 |
| Mar 24, 2025 | ACAD ACADIA PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitsderivative | +6,510 | $0.00 | $0 | 6,510 | Mar 26, 2025 |
| Mar 25, 2025 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitsderivative | -2,142 | $0.00 | $0 | 6,426 | Mar 26, 2025 |
| Feb 23, 2025 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Common Stock | +840 | - | - | 20,703 | Feb 25, 2025 |
| Feb 24, 2025 | ACAD ACADIA PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -475 | $19.96 | $9,481 | 20,228 | Feb 25, 2025 |
| Feb 23, 2025 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitsderivative | -840 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Nov 17, 2024 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Common Stock | +3,965 | - | - | 19,971 | Nov 19, 2024 |
| Nov 17, 2024 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Common Stock | +3,965 | - | - | 23,936 | Nov 19, 2024 |
| Nov 19, 2024 | ACAD ACADIA PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -4,073 | $16.81 | $68k | 19,863 | Nov 19, 2024 |
| Nov 17, 2024 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitsderivative | -3,965 | $0.00 | $0 | 3,966 | Nov 19, 2024 |
| Nov 17, 2024 | ACAD ACADIA PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitsderivative | -3,965 | $0.00 | $0 | 3,966 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.